GNPs-pIL-4 reprograms macrophage polarization and activates the OSM/GSNOR/ENG axis to improve angiogenesis in ischemic limbs
Science Advances · 2026-08-14 · 12 (33)
DOI: 10.1126/sciadv.aed5692 ↗At a glance
Journal article in Science Advances, published on 2026-08-14. Written by Peng Zhang and 21 co-authors. Institution: Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surg…. Major MEDLINE topics: Macrophages, Ischemia, Oncostatin M, Angiogenesis. 40 references. The full text is freely available in PubMed Central. Funded by: National Natural Science Foundation of China.
Abstract (original language)
Therapeutic angiogenesis based on gene therapies is a potential peripheral artery disease (PAD) treatment yet needs a more stable, efficient, and high-affinity delivery vector and an optimized delivery strategy. Here, we engineered three-dimensional graphene nanoparticles modified with folic acid and polyethyleneimine for macrophage-specific delivery of interleukin-4 plasmids (pIL-4), forming GNPs-pIL-4 for local intramuscular injection. GNPs-pIL-4 had uniform size, positive surface charge, and strong nucleic acid loading capacity ( K d : 25 nanomolar). In vivo, GNPs-pIL-4 reshaped the ischemic microenvironment by inducing reparative M2 macrophage polarization. Mediated by macrophages, GNPs-pIL-4 improved muscle contractility, delayed strength loss, and enhanced blood perfusion and oxygen saturation. Mechanistically, GNPs-pIL-4 specifically turned on the oncostatin M–mediated macrophage-endothelium communication and then activated the angiogenesis, with increased endothelial sprouting, migration, and tube formation. These effects attributed to the down-regulated S -nitrosoglutathione reductase expression, thereby increasing S-nitrosylation at the C209 site of endoglin. GNPs-pIL-4 represents a promising gene therapy strategy for PAD.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Department of Interventional Radiology and Vascular Surgery, Third Hospital, Peking University, Beijing, China.
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.
- Tasly Microcirculation Research Center, Peking University Health Science Center, Beijing, China.
- Moxi Technology, Guangzhou, China.
- Star Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China.
- Institute of Advanced Clinical Medicine, Peking University, Beijing, China.
ORCID profiles: Peng Zhang, Jinman Zhuang, Yizhou Hao, Xiangrui Zhu, Hongbiao Liang, Guizimeng Hu, Peiyi Li, Yuwei Song, Qijia Liu, Guangxin Yang, Tianqi Chen, Xinmei Huo, Kai Sun, Li Yan, Chun-Shui Pan, Qihua He, Kuangda Lu, Yang Zhao, Jing-Yan Han, Tianrun Li, Jian-Hao Chen, Juan Feng
Funding
- National Natural Science Foundation of China
Cite
APA
Zhang, P., Zhuang, J., Hao, Y., Zhu, X., Liang, H., Hu, G., Li, P., Song, Y., Liu, Q., Yang, G., Chen, T., Huo, X., Sun, K., Yan, L., Pan, C. S., He, Q., Lu, K., Zhao, Y., Han, J. Y., …, & Feng, J. (2026). GNPs-pIL-4 reprograms macrophage polarization and activates the OSM/GSNOR/ENG axis to improve angiogenesis in ischemic limbs. Science Advances, 12(33). https://doi.org/10.1126/sciadv.aed5692
Vancouver
Zhang P, Zhuang J, Hao Y, Zhu X, Liang H, Hu G, et al. GNPs-pIL-4 reprograms macrophage polarization and activates the OSM/GSNOR/ENG axis to improve angiogenesis in ischemic limbs. Science Advances. 2026;12(33). doi:10.1126/sciadv.aed5692
BibTeX
@article{Zhang2026,
author = {Zhang, Peng and Zhuang, Jinman and Hao, Yizhou and Zhu, Xiangrui and Liang, Hongbiao and Hu, Guizimeng and Li, Peiyi and Song, Yuwei and Liu, Qijia and Yang, Guangxin and Chen, Tianqi and Huo, Xinmei and Sun, Kai and Yan, Li and Pan, Chun-Shui and He, Qihua and Lu, Kuangda and Zhao, Yang and Han, Jing-Yan and Li, Tianrun and Chen, Jian-Hao and Feng, Juan},
title = {GNPs-pIL-4 reprograms macrophage polarization and activates the OSM/GSNOR/ENG axis to improve angiogenesis in ischemic limbs},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {33},
doi = {10.1126/sciadv.aed5692}
}
EUVIMED